Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 21.68
-0.09 (-0.41%)
Jun 6, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Disposable Blood Perfusion Device | 1.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Disposable Blood Perfusion Device Growth | -27.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Purification Equipment | 235.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Purification Equipment Growth | 19.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Disposable Plasma Bilirubin Absorber | 91.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Disposable Plasma Bilirubin Absorber Growth | -20.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hemodialysis Powder and Liquid Products | 56.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hemodialysis Powder and Liquid Products Growth | -24.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 69.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -11.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 1.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -23.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 52.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -16.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|